Anticoagulant use after GI bleed safe

In a prospective study, restarting therapy at discharge was associated with fewer thromboembolic events without a significantly increased risk of recurrent GI bleed at 90 days. 

However, patients whose anticoagulation therapy was discontinued were at greater risk of thrombolytic events at two and eight weeks after discharge. 

According to Gastroenterological Society of Australia spokesperson Dr Cameron Bell, the findings indicate that a brief interruption followed by resumption of anticoagulation after an index GI bleed, on